Number of the records: 1  

Endothelialization of an ePTFE vessel prosthesis modified with an antithrombogenic fibrin/heparin coating enriched with bound growth factors

  1. 1.
    SYSNO ASEP0539970
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleEndothelialization of an ePTFE vessel prosthesis modified with an antithrombogenic fibrin/heparin coating enriched with bound growth factors
    Author(s) Táborská, Johanka (UMCH-V)
    Riedelová, Zuzana (UMCH-V) ORCID
    Brynda, Eduard (UMCH-V) RID
    Májek, P. (CZ)
    Riedel, Tomáš (UMCH-V) RID, ORCID
    Source TitleRSC Advances. - : Royal Society of Chemistry
    Roč. 11, č. 11 (2021), s. 5903-5913
    Number of pages11 s.
    Languageeng - English
    CountryGB - United Kingdom
    Keywordsfibrin coating ; ePTFE vascular graft ; vascular endothelial growth factor
    Subject RIVEI - Biotechnology ; Bionics
    OECD categoryBiomaterials (as related to medical implants, devices, sensors)
    R&D ProjectsGA18-01163S GA ČR - Czech Science Foundation (CSF)
    LQ1604 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    ED1.1.00/02.0109 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Method of publishingOpen access
    Institutional supportUMCH-V - RVO:61389013
    UT WOS000614616900006
    EID SCOPUS85100483467
    DOI10.1039/D1RA00053E
    AnnotationEarly and late thrombosis remain the most frequent reasons for the failure of synthetic cardiovascular grafts. Long-term hemocompatibility of implanted synthetic grafts can be achieved if a natural living endothelium is formed over its blood-contacting surface. Here we present a modification of a standard expanded polytetrafluorethylene (ePTFE) vessel prosthesis by a controlled preparation of a fibrin mesh enriched with covalently bound heparin and noncovalently bound vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF). Compared to a bare prosthesis, the coated prosthesis showed excellent antithrombogenic properties after contact with heparinized fresh human blood. Human umbilical vein endothelial cells seeded on the inner surface of the coated prosthesis formed a confluent layer in 5 days, whereas only small colonies of cells were scattered on the bare prosthesis. Viability of the cells was promoted mainly by FGF immobilized on the coating. These findings suggest that the coating may prevent acute thrombus formation and support the self-endothelialization of an implanted ePTFE vascular graft in vivo.
    WorkplaceInstitute of Macromolecular Chemistry
    ContactEva Čechová, cechova@imc.cas.cz ; Tel.: 296 809 358
    Year of Publishing2022
    Electronic addresshttps://pubs.rsc.org/en/content/articlelanding/2021/RA/D1RA00053E#!divAbstract
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.